227 related articles for article (PubMed ID: 35715800)
1. Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders.
Ghasemian M; Rajabibazl M; Sahebi U; Sadeghi S; Maleki R; Hashemnia V; Mirfakhraie R
Cancer Cell Int; 2022 Jun; 22(1):215. PubMed ID: 35715800
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of long non-coding RNA MR4435-2HG suppresses breast cancer progression via the Wnt/β-catenin signaling pathway.
Chen D; Tang P; Wang Y; Wan F; Long J; Zhou J; Zhuang M; Chen X
Oncol Lett; 2021 May; 21(5):373. PubMed ID: 33777197
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis.
Shen MY; Zhou GR; -Y Zhang Z
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1771-1777. PubMed ID: 32141545
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H
Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MIR4435-2HG recruits miR-802 from FLOT2 to promote melanoma progression.
Ma DM; Sun D; Wang J; Jin DH; Li Y; Han YE
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2616-2624. PubMed ID: 32196611
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling.
Wang H; Wu M; Lu Y; He K; Cai X; Yu X; Lu J; Teng L
Aging (Albany NY); 2019 Sep; 11(17):6657-6673. PubMed ID: 31484163
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.
Ke J; Wang Q; Zhang W; Ni S; Mei H
Am J Transl Res; 2022; 14(8):5441-5454. PubMed ID: 36105009
[TBL] [Abstract][Full Text] [Related]
8. MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis.
Zhong C; Xie Z; Zeng LH; Yuan C; Duan S
Front Immunol; 2022; 13():855078. PubMed ID: 35784328
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
Gao LF; Li W; Liu YG; Zhang C; Gao WN; Wang L
Front Oncol; 2021; 11():661288. PubMed ID: 34532282
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MIR4435-2HG is a potential early diagnostic marker for ovarian carcinoma.
Gong J; Xu X; Zhang X; Zhou Y
Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(9):953-959. PubMed ID: 31435668
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MIR4435-2HG-mediated upregulation of TGF-β1 promotes migration and proliferation of nonsmall cell lung cancer cells.
Yang M; He X; Huang X; Wang J; He Y; Wei L
Environ Toxicol; 2020 May; 35(5):582-590. PubMed ID: 31875359
[TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.
Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y
FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506
[TBL] [Abstract][Full Text] [Related]
13. MIR4435-2HG: A Tumor-associated Long Non-coding RNA.
Zhao F; Liu Y; Tan F; Tang L; Du Z; Mou J; Zhou G; Yuan C
Curr Pharm Des; 2022; 28(25):2043-2051. PubMed ID: 35674305
[TBL] [Abstract][Full Text] [Related]
14. MIR4435-2HG: A newly proposed lncRNA in human cancer.
Zhang M; Yu X; Zhang Q; Sun Z; He Y; Guo W
Biomed Pharmacother; 2022 Jun; 150():112971. PubMed ID: 35447550
[TBL] [Abstract][Full Text] [Related]
15. The lncRNA MIR4435-2HG promotes lung cancer progression by activating β-catenin signalling.
Qian H; Chen L; Huang J; Wang X; Ma S; Cui F; Luo L; Ling L; Luo K; Zheng G
J Mol Med (Berl); 2018 Aug; 96(8):753-764. PubMed ID: 29872866
[TBL] [Abstract][Full Text] [Related]
16. lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression.
Yang T; Li Y; Wang G; Guo L; Sun F; Li S; Deng X; Liu J
Biomed Res Int; 2022; 2022():3858249. PubMed ID: 35993042
[TBL] [Abstract][Full Text] [Related]
17. Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review.
Chen Z; Guan D; Zhu Q; Wang Z; Han F; Zhou W
Curr Issues Mol Biol; 2023 Nov; 45(11):8864-8881. PubMed ID: 37998733
[TBL] [Abstract][Full Text] [Related]
18. Long Non-coding RNA MIR4435-2HG Promotes Colorectal Cancer Proliferation and Metastasis Through miR-206/YAP1 Axis.
Dong X; Yang Z; Yang H; Li D; Qiu X
Front Oncol; 2020; 10():160. PubMed ID: 32154166
[No Abstract] [Full Text] [Related]
19. LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis.
Xiao Y; Bao Y; Tang L; Wang L
J Orthop Surg Res; 2019 Aug; 14(1):247. PubMed ID: 31387631
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MIR4435-2HG inhibits the progression of osteoarthritis through miR-510-3p sponging.
Liu Y; Yang Y; Ding L; Jia Y; Ji Y
Exp Ther Med; 2020 Aug; 20(2):1693-1701. PubMed ID: 32742398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
